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Introduction
Taiwan launched its National Health Insurance (NHI)
program in 1995. Although the NHI has decreased
people’s financial barriers to accessing health care,
escalating medical expenditure have exceeded revenue
from premiums since 1998.1 In light of increasing
medical needs and financial shortage, reform has been
initiated with the goal of establishing an equitable,
efficient and high-quality health care system.2
The introduction of valid risk adjustment mecha-
nisms is widely believed to be crucial to maintaining
equity while pursuing efficiency. In the 1990s, the
Johns Hopkins adjusted clinical groups (ACGs) case-
mix adjustment system was developed using medical
diagnosis codes from administrative data to directly
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quantify the overall requirement for resources based
on diagnoses for individuals.3,4 The ACG system takes
into account a person’s mix of diseases that stretches
across visits, facilities and providers over a defined time
period, typically 1 year. Each ACG category is used as
an estimate for a group of patients with the same con-
stellation of morbidities, thereby indicating the need
for care of each category of patient. The validity and
reliability of the ACG system has been widely evalu-
ated in the United States,3–5 Canada,6,7 and several
European countries.8–13 Previous studies conducted in
these countries found that the ACG system had satis-
factory explanatory ability regarding the variance of
same-year and next-year ambulatory and inpatient
services.4,7,14 Therefore, the ACG system has been
applied to capitation rate adjustment,15,16 performance
profiling,17–20 prediction of resource utilization,21,22
and health services research.23–25 Recently, the explana-
tory ability of the ACG system has been further en-
hanced by adding sophisticated statistical components
such as ACG-predictive modeling (ACG-PM).26
Theoretically, Taiwan’s NHI should be the ideal
setting for adoption of the ACG system because all
required input data are readily available. However, there
have only been 2 studies conducted for the Taiwanese
population, both covering very limited time frames.27,28
Although these studies revealed that the ACG system
worked well for veterans and sampled NHI popula-
tions in a given year, it remains unclear as to whether
or not the explanatory ability is robust across years.
Therefore, the aim of this study was to assess the per-
formance of the ACG system on the NHI population
from a longitudinal perspective.
Methods
Setting and data sources
We conducted longitudinal data analysis using the
claims data of 1% of randomly sampled NHI enrollees
in Taiwan from 2000 to 2004. This data set was issued
by the National Health Research Institutes, Taiwan,
for research purposes. The database provides compre-
hensive individual-level age, gender, ICD-9-CM codes,
and expenditure for each ambulatory and hospital
claim. Encrypted claims data of the sampled cohort
population who were enrolled in the NHI program in
2000 were retrieved and followed-up for 5 years until
December 31, 2004. An individual-specific analytic
file was constructed by retrieving and aggregating each
individual’s age, gender, all diagnosis codes, ambula-
tory visits, ambulatory expenditure, inpatient expen-
diture, and total medical expenditure reimbursed by
the NHI over each 12-month period from 2000 to
2004, respectively.
ADG, ACG and PRI assignment
The ACG software (version 7.0)26 was used without
modification of the developers’ grouping algorithm.
This algorithm enables each diagnosis to be classified
into 1 of 32 clinically cogent morbidity clusters, named
aggregated diagnosis groups (ADGs), according to the
likely persistence of the condition, grade of severity,
etiology, diagnostic certainty, and need for specialty
care. The individual’s total number of unique ADGs,
together with his/her age and gender, are used to group
each case into mutually exclusive morbidity clusters,
named ACGs. Each individual was assigned 1 or more
ADGs but only 1 of the total 89 ACGs in a given year.
ACG-PM is a process that applies existing patients’
risk factor variables to prospectively identify persons
with high medical needs who are at risk for above-
average future medical service utilization. The risk fac-
tor variables used in ACG-PM include: age groups,
sex, ACGs, hospital dominant markers (50% or higher
probability of future admission), dichotomous med-
ically frail markers, and specific disease markers indi-
cating either common high-cost chronic illnesses or
uncommon conditions that have high impact on both
cost and health. The ACG-PM software produces 
2 types of predictive risk factors: first, the probability
score representing the likelihood that a member will
be among those persons using extraordinary health care
resources in the coming year and, second, a predictive
resource index (PRI) that expresses anticipated resource
use as a relative value.26 The PRI is applied to calcu-
late expected resource use in the next year. We calcu-
lated the PRI for each individual based on his/her
prior-year number of visits (PRI-v), ambulatory expen-
diture (PRI-a), inpatient expenditure (PRI-i), and total
NHI expenditure (PRI-t), respectively.
Data analysis
All data were analyzed using STATA version 8 (Stata
Corp., College Park, TX, USA); p values were 2-sided,
with the significance level set at 0.05. The application
of the data sets was reviewed and approved by the
Institutional Review Board of the National Health
Research Institutes. All the personal identifiers were
encrypted and modified to protect patient privacy and
confidentiality before the data were released.
ACGs and utilization distributions
Distributions of the cohort population according to
their assigned ACGs in each year were plotted and
compared using Pearson’s correlation method from
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2000 to 2004. The reasons for ungrouped diagnoses
were examined. We compared the mean number of
visits, and ambulatory, inpatient and total (ambulatory
plus inpatient) expenditure per person per year between
2000 and 2004. Furthermore, we calculated the total
expenditure for each ACG category using 2004 data
to examine the relationship between the population’s
expenditure and their ACG distributions.
Concurrent analysis
The explanatory abilities of ACGs and their ADG com-
ponents regarding same-year variance of visits, and
ambulatory, inpatient and total expenditure were exam-
ined. In accordance with the methodologies used in
previous validation studies,3,11 a series of multivariate
linear regression models were constructed to compare
the abilities of alternative case-mix models to explain
the variance of 99%-truncated (i.e. excluding the top
1% of extremely-high users) visits and expenditure of
each year. Four regression models were used: Model 1a
consisted of each individual’s age and gender; Model 2a
consisted of each individual’s age, gender and total
number of unique ADGs in a given year; Model 3a
consisted of age, gender and 32 ADG dummy variables;
and Model 4a consisted of ACG dummy variables.
The explanatory ability of each model regarding the
variance in visits and expenditure was measured by
adjusted R2.
Prospective analysis
The explanatory abilities of each individual’s ADGs,
ACGs and PRI regarding his/her next-year variance
of 99%-truncated utilization and expenditure were
examined by 6 regression models. Model 1b consisted
of each individual’s age and gender; Model 2b con-
sisted of each individual’s age, gender and total number
of unique ADGs in a given year; Model 3b consisted
of age, gender and 32 ADG dummy variables; Model
4b consisted of ACG dummy variables; and Model 5b
consisted of different kinds of PRI (PRI-v, PRI-a,
PRI-i, PRI-t) as continuous independent variables.
We used prior-year visits, and ambulatory, inpatient
and total expenditure as independent variables in Model
6b to examine the explanatory ability of prior-year
utilization.
Results
ACG assignment
Claims data retrieved from a total of 184,275 sam-
pled cases were used; mean age in 2000 was 33 years.
An average of 98.1% of the total population could be
assigned to 1 of the 89 ACG categories. The grouping
rate was highest in 2003 (99.2%) and lowest in 2002
(97.8%). The reasons for unmatched grouping were
miscoding of age (45%), gender of newborns (21%),
incomplete information on immigrants and laborers
from other countries (14%), and ICD-9 codes (8%).
Table 1 lists the mean number of unique ADGs
per person per year from 2000 to 2004. Some people
were missed, possibly due to moving or studying over-
seas, withdrawal from insurance, or death. People were
assigned to an average of 4.62 unique ADGs in 2000,
and this figure increased continuously to 5.21 in 2004.
The distribution patterns among ACGs were highly
consistent across the 5 years (Figure 1). Pearson’s
correlation coefficient ranged from 0.975 to 0.999
between each year. In 2004, about 9.0% of the total
population was assigned to ACG 0300, followed by
ACG 4910, ACG 2400, ACG 3400, and ACG 1800.
People were unequally distributed among ACGs. The
most assigned 5 ACGs included 34.1% of the total pop-
ulation and the top 25 most assigned ACGs included
80.2% of the total population. The details of ACG
assignment in each year are listed in the Appendix.
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Table 1. Average utilization and expenditure per person per year for the sampled National Health Insurance (NHI) population in Taiwan
from 2000 to 2004*
Year
2000 2001 2002 2003 2004
NHI population (n) 184,275 182,791 178,613 178,698 178,258
Utilization per person per year
Unique ADGs (n) 4.62 ± 0.02 4.68 ± 0.01 4.83 ± 0.01 5.00 ± 0.01 5.21 ± 0.01
Visits (n) 14.3 ± 0.01 14.3 ± 0.03 13.8 ± 0.05 14.2 ± 0.03 14.9 ± 0.04
Ambulatory expenditure 9,996 ± 68 10,486 ± 73 10,798 ± 71 11,655 ± 148 12,662 ± 98
Inpatient expenditure 4,547 ± 91 4,890 ± 104 5,097 ± 102 5,356 ± 112 6,009 ± 123
Total NHI expenditure 14,815 ± 122 15,379 ± 135 15,764 ± 130 16,771 ± 148 18,672 ± 171
*Data presented as mean ± standard error of the mean. ADGs = aggregated diagnosis groups.
Correlations between ACGs and expenditure
Ambulatory and inpatient expenditure increased from
2000 to 2004 (Table 1). Comparing 2004 expenditure
to that in 2000, there was a 26.7% increase in ambula-
tory expenditure and 32.1% increase in inpatient expen-
diture. Moreover, expenditure was disproportionately
concentrated in a few ACGs. In 2004, only 8.9% of the
total population was assigned to ACG 4910, but these
people spent 13.0% of the total expenditure. About
24.4% of the total population were grouped into 6
ACGs (5050, 4920, 5060, 5040, 5070, 4100), but they
spent 50.4% of the total expenditure. Furthermore,
80% of total NHI expenditure was used by people
assigned to 21 out of 89 (23.6%) ACGs.
Concurrent analyses
The explanatory abilities of each regression model to the
variance of same-year visits and expenditure are listed
in Tables 2 and 3. For ambulatory visits, Model 1a ex-
plained only 3.8–6.6% of the variance. The power in-
creased to 57.3% in 2004 after adding the number of
unique ADGs (Model 2a), and to 58.4% after adding
the 32 ADG dummy variables (Model 3a). ACGs alone
(Model 4a) explained 43.0–52.8% of the variance, a
little lower than the ADG-based models. There was a
trend of increasing explanatory ability regarding same-
year visits from 2000 to 2004.
For ambulatory expenditure, Model 1a explained
11.5–13.7% of the variance, and the explanatory ability
increased to 41.4–46.0% in Model 2a and to 46.0–
52.4% in Model 3a. Model 4a explained 41.5–46.6%
of the variance in same-year ambulatory expenditure.
The explanatory ability of all models was quite consis-
tent across years. For inpatient expenditure, Model 1a
explained only 1.0–1.3% of the variance, and the ex-
planatory power increased to 2.1–2.8% for Model 2a,
and to 8.1–9.9% for Model 3a. Model 4a explained
7.8–9.8% of the variance. The explanatory ability to
inpatient expenditure was lower than that to ambula-
tory visits and expenditure.
For total expenditure, Model 1a explained only
3.2–3.9% of the variance, and the explanatory power
increased to 9.0–10.8% for Model 2a and to
16.2–19.2% for Model 3a. Model 4a explained
15.8–18.2% of the variance in same-year total NHI
expenditure.
Prospective analyses
The explanatory abilities of each model regarding the
variance of next-year visits and expenditure are listed
in Tables 2 and 3. For ambulatory visits, Model 1b
explained 4.6–6.7% of the next-year variance.
Adjusted R2 increased to 29.5–33.5% for Model 2b,
31.6–35.4% for Model 3b, and 28.6–32.3% for Model
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Figure 1. National Health Insurance population showed consistent distributions among the adjusted clinical group (ACG) categories
(except ACG 5200) from 2000 to 2004.
4b. PRI-v (Model 5b) explained 17.9–19.7% of the
variance, and prior-year number of visits (Model 6b)
explained 53.3–56.6% of the next-year variance. 
For ambulatory expenditure, Model 1b explained
7.9–9.0% of the next-year variance. This figure
increased to 17.7–18.3% for Model 2b, 21.3–22.1%
for Model 3b, 18.8–19.4% for Model 4b, and to as
high as 23.3–23.4% for Model 5b (PRI-a). Prior-year
ambulatory expenditure explained 29.8–30.9% of the
next-year variance in ambulatory expenditure.
For inpatient expenditure, Model 1b explained only
1.0–1.4% of the next-year variance. The explanatory
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Table 2. Explanatory ability of regression models (in adjusted R2 value) regarding the variance of same-year (concurrent) and next-year
(prospective) ambulatory visits and ambulatory expenditure of each year from 2000 to 2004
Ambulatory visits Ambulatory expenditure
2000 2001 2002 2003 2004 2000 2001 2002 2003 2004
Concurrent analysis
Model 1a: age, gender 0.038 0.045 0.057 0.061 0.066 0.115 0.118 0.137 0.132 0.128
Model 2a: age, gender, 0.441 0.530 0.546 0.554 0.573 0.411 0.460 0.460 0.458 0.459
no. of ADGs
Model 3a: age, gender, 0.457 0.544 0.559 0.566 0.584 0.460 0.521 0.522 0.524 0.524
ADG dummies
Model 4a: ACGs alone 0.430 0.505 0.516 0.513 0.528 0.415 0.466 0.459 0.458 0.456
Prospective analysis
Model 1b: age, gender 0.046 0.054 0.063 0.067 0.079 0.081 0.089 0.090
Model 2b: age, gender, 0.309 0.309 0.295 0.335 0.183 0.177 0.180 0.181
no. of ADGs
Model 3b: age, gender, 0.333 0.334 0.316 0.354 0.221 0.215 0.213 0.214
ADG dummies
Model 4b: ACGs alone 0.323 0.313 0.286 0.319 0.189 0.188 0.193 0.194
Model 5b: PRI by ACG-PM 0.187 0.193 0.179 0.197 0.233 0.236 0.234 0.234
Model 6b: prior-year utilization 0.538 0.555 0.533 0.566 0.298 0.308 0.309 0.301
ADGs = aggregated diagnosis groups; ACGs = adjusted clinical groups; PRI = predictive resource index; ACG-PM = ACG-predictive modeling.
Table 3. Explanatory ability of regression models (in adjusted R2 value) regarding the variance of same-year (concurrent) and next-year
(prospective) inpatient expenditure and total medical expenditure of each year from 2000 to 2004
Inpatient expenditure Total medical expenditure
2000 2001 2002 2003 2004 2000 2001 2002 2003 2004
Concurrent analysis
Model 1a: age, gender 0.010 0.011 0.012 0.013 0.013 0.033 0.032 0.035 0.039 0.038
Model 2a: age, gender, 0.021 0.023 0.023 0.025 0.028 0.098 0.090 0.092 0.108 0.106
no. of ADGs
Model 3a: age, gender, 0.081 0.087 0.088 0.095 0.099 0.171 0.162 0.170 0.192 0.190
ADG dummies
Model 4a: ACGs alone 0.078 0.089 0.090 0.094 0.098 0.158 0.158 0.163 0.182 0.179
Prospective analysis
Model 1b: age, gender 0.010 0.014 0.013 0.014 0.030 0.042 0.040 0.034
Model 2b: age, gender, 0.014 0.019 0.018 0.018 0.055 0.068 0.064 0.058
no. of ADGs
Model 3b: age, gender, 0.034 0.033 0.035 0.034 0.085 0.090 0.088 0.080
ADG dummies
Model 4b: ACGs alone 0.024 0.024 0.027 0.026 0.066 0.070 0.069 0.065
Model 5b: PRI by ACG-PM 0.039 0.048 0.045 0.043 0.104 0.101 0.093 0.083
Model 6b: prior-year utilization 0.110 0.093 0.088 0.086 0.093 0.094 0.088 0.082
ADGs = aggregated diagnosis groups; ACGs = adjusted clinical groups; PRI = predictive resource index; ACG-PM = ACG-predictive modeling.
ability increased to 1.4–1.9% for Model 2b, 3.3–3.5%
for Model 3b, and 2.4–2.7% for Model 4b. PRI-i
explained 3.9–4.8% of the next-year variance. Prior-
year inpatient expenditure explained 8.6–11.0% of the
next-year variance. For total expenditure, Model 1b
explained only 3.0–4.2% of the next-year variance. It
increased to 5.5–6.8% for Model 2b, 8.0–9.0% for
Model 3b, and 6.5–7.0% for Model 4b. PRI-t ex-
plained 8.3–10.4% of the next-year variance, which was
compatible with the explanatory ability by prior-year
total medical expenditure (8.2–9.4%).
Discussion
The ACG system worked well across years
Our study shows that the majority of the NHI popu-
lation can be appropriately assigned to ACG cate-
gories. There are several advantages to adopting the
ACG system in Taiwan. First, the administrative barri-
ers are low for providers because they have used the
ICD-9-CM coding system and uploaded the data to
the Bureau of NHI (BNHI) on a regular basis since
2000. As a single-payer system, the BNHI possesses
all required inputs on a national basis for operating
the ACG system. Second, although the accuracy of
diagnosis coding has not been verified, the coding
quality is acceptable for the purpose of running the
ACG system given that the percentage of non-grouped
diagnosis codes was considerably lower than the 5%
recommended by the developers.26 Third, the reli-
ability of the system is also recognized given the find-
ing that the distributions of ACGs were highly
consistent for the cohort population across 5 years.
Satisfactory explanatory ability
This study found that the explanatory ability of the
ACG system was quite stable across years and com-
patible with previous studies conducted in other
countries.3,7,11,12 Regarding the variance of same-year
ambulatory expenditure, the explanatory power of
the ADG-based model to the Taiwanese population
was quite similar to that of people in the United
States (42–49%)3 and Canada (Manitoba, 50.1%).7
The explanatory power of the ACG-based model 
was nearly the same between Taiwan (41–46%) and
Manitoba, Canada,7 and was a little higher than that
in the United States (34–39%)3 and Sweden (38%).11
The explanatory ability for next-year ambulatory
expenditure of the NHI population (20–22%) was
also similar to that of the United States (18–21%)3
and Canada (21–26%).7 This international compara-
bility is noteworthy given the differences in the health
care delivery and reimbursement systems and people’s
behaviors between Taiwan and those countries.
However, some limitations to the generalizability
of our results should be mentioned. First, the accu-
racy of these diagnoses has not been systematically es-
timated and, thus, the validity of the ACG system is
still potentially threatened by the degree of coding
accuracy. However, compared to other encounter-based
systems, the ACG system is relatively robust because
the exact diagnostic code is not of prime importance
to the system. The crucial point is that the code be-
longs to the right cluster of diagnoses in terms of
ADGs, resulting in the expression of each patient’s
health status as a combination of different types of
morbidity.10 Second, clinicians might assign provi-
sional diagnoses in the first few encounters. The in-
clusion of provisional diagnoses may cause an increase
in the ability of case-mix to explain ambulatory
expenditure. Third, the explanatory ability of the ACG
system regarding ambulatory visits and expenditure
was significantly better than inpatient and total expen-
diture. The ACG system was originally designed for
ambulatory use, and inpatient expenditure might be
too diverse to fit the limited number of ACG cate-
gories. Fourth, because claims data are highly pro-
tected, they could not be linked to other databases,
and so we examined only how well ACGs explained
what levels of services were actually provided rather
than those that were really needed.
Policy implications
Recent studies have found that an individual’s health
care needs and costs are correlated with his/her total
morbidity burdens instead of the particular disease
he/she may have.29,30 Therefore, accurate methods
are needed for estimating an individual’s and a popu-
lation’s morbidity burdens, otherwise, the payment
scheme would be misaligned with health care needs.7
Traditionally, age and gender data were widely used
for risk adjustment because they are easy to get and
hard to manipulate. This study, as well as other studies
conducted in Sweden (11.4%),11 Canada (Manitoba,
8.1%),7 and the United States (3–6%),3 highlights the
limitations of age and gender in risk adjustment. On
the other hand, prior utilization and expenditure had
the highest predictive ability, but their disadvantage 
is to encourage utilization rather than efficiency. For
many countries and insurers, population morbidity
burdens have replaced or added to the original demo-
graphic data and prior utilization in the equation of
resource allocation. For instance, the Risk Adjustment
Reform Act of Germany mandates the move from 
a demographics-based (age, sex, disability status) to 
J Chin Med Assoc • April 2008 • Vol 71 • No 4196
W.C. Lee, T.P. Huang
a morbidity-based case-mix adjustment mechanism to
allocate resources among sicknesses.31
We suggest that the ACG system can be applied to
measure morbidity burdens on a population basis in
Taiwan. The Department of Health or the BNHI can
use the ACG system to obtain information on peo-
ple’s morbidity burdens rather than just on disease
patterns. The same method can also be applied to cer-
tain groups of people, such as servicemen, veterans,
farmers, and aborigines, for the purpose of comparing
their morbidity patterns to those of the general popu-
lation. Furthermore, the annual total budget of the
NHI program is capped for cost containment. Budget
allocation is mainly based on residents’ mean age,
gender, standardized mortality rate, and prior-year
expenditure of a given NHI administrative branch.
Residents’ morbidity burdens have not yet been con-
sidered as predictors of next-year expenditure. More
studies are needed to assess the feasibility of adding
ACG-based morbidity burden variables in budget
allocation equations, especially for ambulatory care
budget.
In conclusion, our study found substantial feasibil-
ity and reliability in the ACG system to measure 
morbidity burdens and to explain the variance of am-
bulatory visits and expenditure of the Taiwanese pop-
ulation. Although the quality of diagnosis coding
needs to be continuously improved, appropriate use
of the ACG system can aid health care authorities in
their efforts toward an equitable and efficient NHI.
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Appendix. Distributions of the cohort population among adjusted clinical groups (ACGs) in Taiwan from 2000 to 2004
ACG description
Frequency (%)
2000 2001 2002 2003 2004
0100 Acute minor, age 1 0.270 0.200 – – –
0200 Acute minor, age 2–5 0.888 0.918 0.846 0.574 0.565
0300 Acute minor, age ≥ 6 10.004 9.701 10.420 9.170 9.005
0400 Acute: major 0.801 0.742 0.853 0.840 0.825
0500 Likely to recur, without allergies 0.813 0.743 0.857 0.855 0.840
0600 Likely to recur, with allergies 0.131 0.120 0.128 0.131 0.129
0700 Asthma 0.006 0.007 0.007 0.008 0.008
0800 Chronic medical, unstable 0.128 0.133 0.132 0.151 0.148
0900 Chronic medical, stable 0.241 0.238 0.258 0.258 0.253
1000 Chronic specialty 0.023 0.017 0.023 0.021 0.021
1100 Ophthalmologic/dental 2.116 2.186 1.540 2.190 2.151
1200 Chronic specialty, unstable 0.014 0.021 0.016 0.019 0.019
1300 Psychosocial, without psychosocial unstable 0.028 0.032 0.036 0.033 0.032
1400 Psychosocial, with unstable, without stable 0.053 0.047 0.066 0.044 0.044
1500 Psychosocial, with unstable and stable 0.012 0.011 0.009 0.013 0.012
1600 Preventive/administrative 0.152 0.169 0.188 0.224 0.220
1711 Pregnancy, 0–1 ADG, delivered 0.001 0.000 0.001 0.001 0.001
1712 Pregnancy, 0–1 ADG, not delivered 0.016 0.014 0.011 0.016 0.015
1721 Pregnancy, 2–3 ADGs, no major ADG, delivered 0.004 0.003 0.002 0.003 0.003
1722 Pregnancy, 2–3 ADGs, no major ADG, not delivered 0.169 0.154 0.139 0.137 0.134
1731 Pregnancy, 2–3 ADGs, ≥ 1 major ADG, delivered 0.000 0.001 0.001 0.002 0.002
1732 Pregnancy, 2–3 ADGs, ≥ 1 major ADG, not delivered 0.024 0.018 0.019 0.010 0.010
1741 Pregnancy, 4–5 ADGs, no major ADG, delivered 0.006 0.006 0.003 0.004 0.004
1742 Pregnancy, 4–5 ADGs, no major ADG, not delivered 0.401 0.339 0.351 0.331 0.325
1751 Pregnancy, 4–5 ADGs, ≥ 1 major ADG, delivered 0.002 0.003 0.005 0.002 0.002
1752 Pregnancy, 4–5 ADGs, ≥ 1 major ADG, not delivered 0.136 0.118 0.115 0.099 0.098
1761 Pregnancy, ≥ 6 ADGs, no major ADG, delivered 0.009 0.009 0.007 0.008 0.008
1762 Pregnancy, ≥ 6 ADGs, no major ADG, not delivered 0.616 0.552 0.564 0.553 0.543
1771 Pregnancy, ≥ 6 ADGs, ≥ 1 major ADG, delivered 0.018 0.017 0.017 0.014 0.014
1772 Pregnancy, ≥ 6 ADGs, ≥ 1 major ADG, not delivered 0.962 0.900 0.932 0.911 0.895
1800 Acute minor and acute major 4.365 4.519 4.808 4.009 3.937
1900 Acute minor and likely to recur, age 1 0.270 0.190 – – –
2000 Acute minor and likely to recur, age 2–5 0.590 0.581 0.644 0.422 0.415
2100 Acute minor and likely to recur, age > 5, without allergy 4.284 4.280 4.904 4.219 4.143
2200 Acute minor and likely to recur, age > 5, with allergy 1.182 1.188 1.420 1.307 1.283
2300 Acute minor and chronic medical: stable 1.023 1.005 1.180 1.044 1.026
(Continued)
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ACG description
Frequency (%)
2000 2001 2002 2003 2004
2400 Acute minor and eye/dental 7.171 7.516 5.780 6.853 6.730
2500 Acute minor, psychosocial, without unstable 0.090 0.109 0.103 0.105 0.103
2600 Acute minor, psychosocial, unstable without stable 0.038 0.044 0.044 0.038 0.037
2700 Acute minor, psychosocial, with unstable and stable 0.009 0.009 0.017 0.019 0.018
2800 Acute major and likely to recur 0.364 0.378 0.419 0.402 0.395
2900 Acute minor and major/likely to recur, age 1 0.330 0.310 – – –
3000 Acute minor and major/likely to recur, age 2–5 0.603 0.660 0.783 0.436 0.428
3100 Acute minor and major/likely to recur, age 6–11 0.312 0.254 0.363 0.258 0.254
3200 Acute minor and major/likely to recur, age ≥ 12, without allergy 3.681 3.672 4.265 3.615 3.550
3300 Acute minor and major/likely to recur, age ≥ 12, with allergy 0.757 0.787 0.989 0.916 0.898
3400 Acute minor/likely to recur/eye and dental 5.413 5.576 4.800 5.723 5.621
3500 Acute minor/likely to recur/psychosocial 0.181 0.162 0.207 0.169 0.166
3600 Acute minor/major/likely to recur/chronic medical: stable 2.523 2.497 3.206 2.847 2.796
3700 Acute minor and major/likely to recur/psychosocial 0.276 0.284 0.349 0.289 0.284
3800 2–3 other ADG combinations, age 1–17 1.097 1.119 0.953 0.937 0.920
3900 2–3 other ADG combinations, male, age 18–34 1.043 1.108 0.947 1.010 0.992
4000 2–3 other ADG combinations, female, age 18–34 0.675 0.642 0.618 0.648 0.636
4100 2–3 other ADG combinations, age > 34 3.202 3.338 3.409 3.674 3.608
4210 4–5 other ADG combinations, age 1–17, no major ADG 2.661 2.595 2.360 2.394 2.352
4220 4–5 other ADG combinations, age 1–17, ≥ 1 major ADGs 0.639 0.590 0.581 0.474 0.466
4310 4–5 other ADG combinations, age 18–44, no major ADGs 2.487 2.536 2.431 2.718 2.668
4320 4–5 other ADG combinations, age 18–44, 1 major ADG 2.464 2.603 2.377 2.363 2.322
4330 4–5 other ADG combinations, age 18–44, ≥ 2 major ADGs 0.537 0.499 0.532 0.475 0.467
4410 4–5 other ADG combinations, age > 44, no major ADGs 1.515 1.590 1.657 1.868 1.834
4420 4–5 other ADG combinations, age > 44, 1 major ADG 2.018 2.119 2.204 2.251 2.210
4430 4–5 other ADG combinations, age > 44, ≥ 2 major ADGs 0.652 0.672 0.713 0.735 0.722
4510 6–9 other ADG combinations, age 1–5, no major ADGs 0.977 0.879 0.793 0.689 0.679
4520 6–9 other ADG combinations, age 1–5, ≥ 1 major ADGs 0.350 0.312 0.241 0.176 0.174
4610 6–9 other ADG combinations, age 6–17, no major ADGs 1.599 1.691 1.739 2.058 2.020
4620 6–9 other ADG combinations, age 6–17, ≥ 1 major ADGs 0.586 0.547 0.643 0.666 0.654
4710 6–9 other ADG combinations, male, age 18–34, no major ADGs 0.401 0.413 0.433 0.527 0.517
4720 6–9 other ADG combinations, male, age 18–34, 1 major ADG 0.726 0.801 0.762 0.930 0.913
4730 6–9 other ADG combinations, male, age 18–34, ≥ 2 major ADGs 0.481 0.542 0.543 0.549 0.540
4810 6–9 other ADG combinations, female, age 18–34, no major ADGs 1.029 1.096 1.029 1.216 1.194
4820 6–9 other ADG combinations, female, age 18–34, 1 major ADG 1.260 1.238 1.261 1.342 1.317
4830 6–9 other ADG combinations, female, age 18–34, ≥ 2 major ADGs 0.486 0.468 0.479 0.457 0.449
4910 6–9 other ADG combinations, age > 34, 0–1 major ADG 8.005 8.355 8.423 9.086 8.923
4920 6–9 other ADG combinations, age > 34, 2 major ADGs 3.177 3.221 3.384 3.358 3.298
4930 6–9 other ADG combinations, age > 34, 3 major ADGs 0.861 0.889 0.895 0.866 0.850
4940 6–9 other ADG combinations, age > 34, ≥ 4 major ADGs 0.136 0.131 0.163 0.142 0.139
5010 ≥ 10 other ADG combinations, age 1–17, no major ADGs 0.172 0.177 0.192 0.195 0.191
5020 ≥ 10 other ADG combinations, age 1–17, 1 major ADG 0.147 0.147 0.156 0.135 0.132
5030 ≥ 10 other ADG combinations, age 1–17, ≥ 2 major ADGs 0.060 0.052 0.051 0.037 0.036
5040 ≥ 10 other ADG combinations, age ≥ 18, 0–1 major ADG 2.336 2.335 2.499 2.846 2.795
5050 ≥ 10 other ADG combinations, age ≥ 18, 2 major ADGs 2.669 2.685 2.818 2.961 2.908
5060 ≥ 10 other ADG combinations, age ≥ 18, 3 major ADGs 1.665 1.669 1.783 1.916 1.881
5070 ≥ 10 other ADG combinations, age ≥ 18, ≥ 4 major ADGs 0.813 0.822 0.886 0.959 0.942
5110 No diagnosis or only unclassified diagnosis 0.580 0.620 – – –
5310 Infants: 0–5 ADGs, no major ADGs 0.820 – – – –
5320 Infants: 0–5 ADGs, 1 major ADG 0.060 – – – –
5330 Infants: ≥ 6 ADGs, no major ADGs 0.070 – – – –
5340 Infants: ≥ 6 ADGs, ≥ 1 major ADGs 0.040 – – – –
